William Blair Initiates Coverage on Perrigo (PRGO) with an Outperform
More News related to PRGO
- RBC Initiates Coverage on Perrigo (PRGO) with an Outperform
- Perrigo Company To Present at the Sidoti Emerging Growth Conference
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Perrigo Company to Present at the Credit Suisse 18th Annual Health Care Conference
- Perrigo (PRGO) Tops Q3 Views; Raises FY10 Outlook
More News related to New Coverage
- Somaxon (SOMX) Volatile Into FDA Action Date
- Vivus (VVUS) Higher Ahead of Qnexa NDA
- Cardium (CXM) Subsidiary Files 510(k) with U.S. FDA for Excellagen Marketing Clearance
- Cardium (CXM) Files FDA 510(k) Application for Marketing Clearance of ExcellagenXL(TM) Topical Gel and Flowable Collagen
- Spectranetics (SPNC) Receives U.S. FDA OK for VisiSheath Dilator Sheath Device
William Blair initiates coverage on Perrigo (Nasdaq: PRGO) with an Outperform.
To see more analyst ratings on PRGO Click Here.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products.
Related Categories
New CoverageStocks Mentioned
-0.43Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
